Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP637883.RAJUb4qvJ5B7LOWBaptCTCHN8gU0rVR0-xkdjWwmqPSMc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP637883.RAJUb4qvJ5B7LOWBaptCTCHN8gU0rVR0-xkdjWwmqPSMc130_assertion type Assertion NP637883.RAJUb4qvJ5B7LOWBaptCTCHN8gU0rVR0-xkdjWwmqPSMc130_head.
- NP637883.RAJUb4qvJ5B7LOWBaptCTCHN8gU0rVR0-xkdjWwmqPSMc130_assertion wasGeneratedBy ECO_0000203 NP637883.RAJUb4qvJ5B7LOWBaptCTCHN8gU0rVR0-xkdjWwmqPSMc130_provenance.
- NP637883.RAJUb4qvJ5B7LOWBaptCTCHN8gU0rVR0-xkdjWwmqPSMc130_assertion wasDerivedFrom befree-2016 NP637883.RAJUb4qvJ5B7LOWBaptCTCHN8gU0rVR0-xkdjWwmqPSMc130_provenance.
- NP637883.RAJUb4qvJ5B7LOWBaptCTCHN8gU0rVR0-xkdjWwmqPSMc130_assertion SIO_000772 17971485 NP637883.RAJUb4qvJ5B7LOWBaptCTCHN8gU0rVR0-xkdjWwmqPSMc130_provenance.
- NP637883.RAJUb4qvJ5B7LOWBaptCTCHN8gU0rVR0-xkdjWwmqPSMc130_assertion evidence source_evidence_literature NP637883.RAJUb4qvJ5B7LOWBaptCTCHN8gU0rVR0-xkdjWwmqPSMc130_provenance.
- NP637883.RAJUb4qvJ5B7LOWBaptCTCHN8gU0rVR0-xkdjWwmqPSMc130_assertion description "[Further, we identify a novel subgroup of patients with CLL with early progressive disease that appears particularly sensitive to MDM2 inhibitor treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP637883.RAJUb4qvJ5B7LOWBaptCTCHN8gU0rVR0-xkdjWwmqPSMc130_provenance.